Rua Life Sciences Share Discussion Threads

[letsbuy1] 11/4/2024 17:52

Lovely 410000 buy just shown up. Thats why it was NT to buy all day and you could off load as many as you wanted. They got there buy order in

[letsbuy1] 11/4/2024 17:29

Albert is winning in points for. D. I. C. K Of the week currently
Looking like he will take the title

[albert35911] 11/4/2024 15:43

Did it open up at 12p this morning,says it all I think people.

[hedgehog11] 11/4/2024 15:33

There's nothing worth saying on this until RUA post a solid achievement. Seems to me the last RNS was positively received purely because it didn't contain any negative news. The LSE board has more activity than here but mostly people reading charts and activity reports and proclaiming the price is about to explode. Not sure if they are actually analysing something or just ramping, but they overlook the reasons why RUA are where they are. From past experience, having the money to fund two or three years is not enough, they need that new manufacturing contract and they haven't stated how long it may take to convert it, assuming they get it.

[letsbuy1] 11/4/2024 09:25

Very quiet on here

[letsbuy1] 10/4/2024 21:03

Think we are in for a few good weeks

[letsbuy1] 10/4/2024 20:24

Lot of them though… Do

[toffeeman] 10/4/2024 18:38

>> Let - it a meagre £10k trade - insignificant

[letsbuy1] 10/4/2024 17:50

Oh look a 94000 trade just popped up.
Filling that all day as there is no stock about. Will open up over the 12 in morning. 14/15p Friday

[albert35911] 10/4/2024 15:59

And it will do nothing

[albert35911] 10/4/2024 15:58

Just had a PM from one of the rampers,they don’t like getting kicked.

[letsbuy1] 10/4/2024 15:50

Check the late trade when it comes through you T. W. A T

[albert35911] 10/4/2024 15:44

Can anyone smell BS.

[letsbuy1] 10/4/2024 15:32

94000 shares buy just gone through. Big buys arriving

[letsbuy1] 10/4/2024 09:13

Big push up any sec. They are searching for stock. No float at all

[letsbuy1] 10/4/2024 08:58

Dropping it to gather shares. Dont give it to them.. this will be 13/14p later today

[early not wrong] 09/4/2024 09:26

Timely update.
No horrors for once.
So much potential but can they finally deliver.
My guess is Ian Ardill will be playing a key role in the graft project given his background and experience.
We will see chop with every move up as the placing supporters take their slim gains.
Ultimately, Mr Brown needs to turn this around from the dog it has become, something he mentioned that he would target doing following the name change from AOR.

[parob] 08/4/2024 13:48

Hopefully see some healthy consolidation around this level before the next leg up.

[rivaldo] 08/4/2024 09:41

Cavendish retain their 25p price target in their update this morning (with a £7.8m m/cap at 12.5p).

Brief extracts:

"Strong strategic progress

RUA Life Sciences has provided a business update for the year to March 2024, noting revenue shortfalls experienced in H1/24 have been made up by a strong second half. Revenues for the year are therefore expected to be in-line with our forecast £2.2m, while the company notes gross margin will exceed our forecasts, with operating costs remaining tightly controlled.

RUA Life Sciences closed FY24 with cash of c£4.0m versus our £3.3m estimate. The company reports significant progress towards its goal of near-term profitability through growing its contract manufacturing business, noting strong progress with a ‘global enterprise’. Finally, RUA has completed a Material Transfer Agreement with a global Heart Valve company covering its composite heart valve material. We believe this update demonstrates excellent progress against the company’s revised strategy."

"Strategy – As noted with its successful fundraise in December 2023, RUA’s revised strategy will seek to grow its Contract Manufacturing business, generating long-term contract revenues, explore third-party funding for its vascular graft portfolio and pursue licence opportunities for its composite heart valve material. We believe this business update demonstrates strong progress against this strategy.

- Investment thesis – We believe the combination of established revenues with growth potential and the option to deliver significant returns through the disruption of established billion-dollar global cardiovascular markets makes RUA Life Sciences an attractive investment opportunity. RUA now aims to turn profitable in the short term and has adopted a strategy to deliver earlier returns on its Vascular and Structural Heart investments."

[harrogate] 07/4/2024 15:00

I think operating costs excludes COS without much doubt. But let's see numbers when they come out

[bones] 07/4/2024 14:00

You may have a point there Harrogate. I was assuming the reference to operating costs was all costs since he paired it with a gross revenue number. These updates always seem to contain a certain amount of ambiguity!